Posts

Showing posts with the label Emphysema competitive landscape

Emphysema – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
 Emphysema is a lung disease that affects the alveoli (tiny air sacs). The alveoli become abnormally inflated in emphysema, damaging their walls and making breathing difficult. Emphysema is a type of COPD (chronic obstructive pulmonary disease). The cause of emphysema is usually long-term exposure to irritants that damage your lungs and the airways. ·        The prevalence of emphysema in the United States is approximately 14 million, which includes 14% white male smokers and 3% white male nonsmokers. The prevalence is slightly less for white female smokers and African Americans.   Thelansis’s “Emphysema Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Emphys...

Emphysema – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032

Image
 Emphysema is a lung disease that affects the alveoli (tiny air sacs). The alveoli become abnormally inflated in emphysema, damaging their walls and making breathing difficult. Emphysema is a type of COPD (chronic obstructive pulmonary disease). The cause of emphysema is usually long-term exposure to irritants that damage your lungs and the airways. ·        The prevalence of emphysema in the United States is approximately 14 million, which includes 14% white male smokers and 3% white male nonsmokers. The prevalence is slightly less for white female smokers and African Americans. Thelansis’s “Emphysema Market Outlook, Epidemiology, Competitive Landscape , and Market Forecast Report – 2021 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Emphysema trea...

Emphysema – Market outlook, Epidemiology, Competitive Landscape and Market Forecast Report – 2020 To 2030

Image
  A disorder affecting the alveoli (tiny air sacs) of the lungs. In emphysema, the alveoli become abnormally inflated, damaging their walls and making it harder to breathe.   Emphysema is a type of COPD (chronic obstructive pulmonary disease).   Etiology- The cause of emphysema is usually long-term exposure to irritants that damage your lungs and the airways. In the United States, cigarette smoke is the main cause. Pipe, cigar, and other types of tobacco smoke can also cause emphysema, especially if someone inhales them. Rarely, a genetic condition called alpha-1 antitrypsin deficiency can play a role in causing emphysema.   Epidemiology- The prevalence of emphysema in the United States is approximately 14 million, which includes 14% white male smokers and 3% white male nonsmokers. The prevalence is slightly less for white female smokers and African Americans. In 2016, the Global Burden of Disease Study reported a prevalence of 251 million cases of COPD...